ZHESHANG SECURITIES·2026-01-08 11:51Investment Rating - The investment rating for China Pacific Insurance (601601) is "Buy" (maintained) [5] Core Views - China Pacific Insurance, as the only listed insurance company backed by the Shanghai State-owned Assets Supervision and Administration Commission, is expected to benefit from its deepening transformation and forward-looking layout in the Web3 sector, potentially leading to a dual boost in performance and valuation [1] - The strategic importance of the insurance industry is increasing, with significant expectations for China Pacific Insurance's transformation in life insurance and support from the Shanghai State-owned Assets [2] - The company is positioned to experience strong growth in new business value (NBV) due to its ongoing transformation initiatives and strategic support from its major shareholder [3] - The forward-looking layout in the Web3 sector is anticipated to drive valuation increases for China Pacific Insurance [4] Summary by Relevant Sections Super Expectation Points - The strategic importance of the insurance industry has been recognized, with the release of new policies promoting high-quality transformation [2] - The risk of interest spread losses is easing, with a continuous reduction in liability costs and an expected increase in investment returns from the equity market [3] - The implementation of the "North Star Plan" is expected to significantly boost NBV, with a notable increase in the agent workforce and a substantial rise in NBV from the bancassurance channel [3] - The strategic support from the Shanghai State-owned Assets is crucial for the company's high-quality development [3] - China Pacific Insurance's proactive engagement in the Web3 sector is expected to enhance its market position [4] Financial Forecasts - Projected net profit growth rates for 2025E-2027E are 6.2%, 21.2%, and 29.4% respectively, with corresponding PEV ratios of 0.77x, 0.71x, and 0.65x [9] - The target price based on a 0.9x PEV for 2026 is set at ¥60.85, indicating a potential upside of 27% [11] Financial Summary - For 2025E, the expected operating revenue is ¥419,626 million, with a net profit of ¥47,769 million [11] - The company is expected to maintain a strong performance with a significant increase in NBV and investment income [11]